Promise of exercise in a pill as Atrogi pivots from type 2 diabetes to obesity
Atrogi AB is making a bid for a slice of the obesity market and has dosed the first overweight subjects with ATR-258, an oral therapy it says mimics the effects of exercise, driving loss of fat whilst sparing muscle.
NM
nuala moran
via Bioworld
Updated 18h ago

Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Eurosets Launches U.S. Commercialization of Trilly and Horizon Following FDA Clearance and Enters Strategic Partnership with Orion Medical
Next
Heart benefits fade after stopping GLP-1 medications
Related Articles
Science【AICC Original Article】Appreciating the Grand Canal through Rows of Willows: A Time-honored Cultural Pulse Reinvigorated
Unknown-5h ago-1 sources
One Dead, Three Trapped After Kericho Building Collapses
Unknown-9h ago-1 sources
ScienceHow AI-generated videos are distorting your child’s YouTube feed
Merinvarghese-10h ago-1 sources